Loading clinical trials...
Loading clinical trials...
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue (PRESERVE GBM)
To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida, United States
Start Date
December 11, 2024
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2029
Last Updated
February 4, 2026
120
ESTIMATED participants
Specimen Collection
PROCEDURE
Lead Sponsor
Baptist Health South Florida
Collaborators
NCT06860594
NCT05839379
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions